Medicines called danazol and oxandrolone can help reduce the chances of swelling occurring if you have hereditary angioedema. These medicines boost the levels of C1 esterase inhibitor in your blood. Low levels of this substance are what causes the swelling.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Hereditary Angioedema Treatment industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Market Segment by Product Application
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Finally, the report provides detailed profile and data information analysis of leading company.
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Hereditary Angioedema Treatment consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Hereditary Angioedema Treatment market by identifying its various subsegments.
3.Focuses on the key global Hereditary Angioedema Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Hereditary Angioedema Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Hereditary Angioedema Treatment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Hereditary Angioedema Treatment Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Hereditary Angioedema Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Hereditary Angioedema Treatment Segment by Type
2.1.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
2.1.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
2.1.3 Kallikrein Inhibitors (Kalbitor, Takhzyro)
2.1.4 Others (Conventional Drugs, Pipeline Drugs)
2.2 Market Analysis by Application
2.2.1 Hospital Pharmacies
2.2.2 Retail Pharmacies
2.2.3 Others (online pharmacies, mail pharmacies)
2.3 Global Hereditary Angioedema Treatment Market Comparison by Regions (2017-2027)
2.3.1 Global Hereditary Angioedema Treatment Market Size (2017-2027)
2.3.2 North America Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.3.3 Europe Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.3.4 China Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.3.5 Japan Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.3.6 Southeast Asia Hereditary Angioedema Treatment Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Hereditary Angioedema Treatment Industry Impact
2.5.1 Hereditary Angioedema Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Hereditary Angioedema Treatment Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Hereditary Angioedema Treatment Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Hereditary Angioedema Treatment Manufacturer Market Share
3.5 Top 10 Hereditary Angioedema Treatment Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Hereditary Angioedema Treatment Market
3.7 Key Manufacturers Hereditary Angioedema Treatment Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Hereditary Angioedema Treatment Industry Key Manufacturers
4.1 CSL
4.1.1 Compan Detail
4.1.2 CSL Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.1.3 CSL 137 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 CSL News
4.2 Pharming Group
4.2.1 Compan Detail
4.2.2 Pharming Group Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 CSL News
4.3 Shire plc (Takeda Pharmaceutical Company Limited)
4.3.1 Compan Detail
4.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Shire plc (Takeda Pharmaceutical Company Limited) News
4.4 Ionis Pharmaceuticals
4.4.1 Compan Detail
4.4.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Ionis Pharmaceuticals News
4.5 Attune Pharmaceuticals
4.5.1 Compan Detail
4.5.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Attune Pharmaceuticals News
4.6 BioCryst Pharmaceuticals
4.6.1 Compan Detail
4.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 BioCryst Pharmaceuticals News
4.7 KalVista Pharmaceuticals
4.7.1 Compan Detail
4.7.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Introduction, Application and Specification
4.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
5 Global Hereditary Angioedema Treatment Market Segment by Big Type
5.1 Global Hereditary Angioedema Treatment Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Hereditary Angioedema Treatment Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Big Type (2017-2022)
5.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate and Price
5.2.1 Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate (2017-2022)
5.2.2 Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Price (2017-2022)
5.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate and Price
5.3.1 Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate (2017-2022)
5.3.2 Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Price (2017-2022)
5.4 Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate and Price
5.4.1 Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate (2017-2022)
5.4.2 Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Price (2017-2022)
5.5 Others (Conventional Drugs, Pipeline Drugs) Sales Growth Rate and Price
5.5.1 Global Others (Conventional Drugs, Pipeline Drugs) Sales Growth Rate (2017-2022)
5.5.2 Global Others (Conventional Drugs, Pipeline Drugs) Price (2017-2022)
6 Global Hereditary Angioedema Treatment Market Segment by Big Application
6.1 Global Hereditary Angioedema Treatment Sales Market Share by Big Application (2017-2022)
6.2 Hospital Pharmacies Sales Growth Rate (2017-2022)
6.3 Retail Pharmacies Sales Growth Rate (2017-2022)
6.4 Others (online pharmacies, mail pharmacies) Sales Growth Rate (2017-2022)
7 Global Hereditary Angioedema Treatment Forecast
7.1 Global Hereditary Angioedema Treatment Revenue, Sales and Growth Rate (2022-2027)
7.2 Hereditary Angioedema Treatment Market Forecast by Regions (2022-2027)
7.2.1 North America Hereditary Angioedema Treatment Market Forecast (2022-2027)
7.2.2 Europe Hereditary Angioedema Treatment Market Forecast (2022-2027)
7.2.3 China Hereditary Angioedema Treatment Market Forecast (2022-2027)
7.2.4 Japan Hereditary Angioedema Treatment Market Forecast (2022-2027)
7.2.5 Southeast Asia Hereditary Angioedema Treatment Market Forecast (2022-2027)
7.2.6 Other Regions Hereditary Angioedema Treatment Market Forecast (2022-2027)
7.3 Hereditary Angioedema Treatment Market Forecast by Type (2022-2027)
7.3.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2022-2027)
7.3.2 Global Hereditary Angioedema Treatment Market Share Forecast by Type (2022-2027)
7.4 Hereditary Angioedema Treatment Market Forecast by Application (2022-2027)
7.4.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2022-2027)
7.4.2 Global Hereditary Angioedema Treatment Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Hereditary Angioedema Treatment Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Hereditary Angioedema Treatment Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Hereditary Angioedema Treatment
Figure Market Concentration Ratio and Market Maturity Analysis of Hereditary Angioedema Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Hereditary Angioedema Treatment Market Size by Big Type
Figure Global Market Share of Hereditary Angioedema Treatment by Big Type in 2021
Figure C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Picture (2017-2022)
Figure Selective Bradykinin B2 Receptor Antagonists (Firazyr) Picture (2017-2022)
Figure Kallikrein Inhibitors (Kalbitor, Takhzyro) Picture (2017-2022)
Global Hereditary Angioedema Treatment Market Size by Big Application
Table Global Hereditary Angioedema Treatment Market Size by Application
Figure Global Hereditary Angioedema Treatment Market Share by Big Application in 2021
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Others (online pharmacies, mail pharmacies) Picture
Table Global Hereditary Angioedema Treatment Comparison by Regions (M USD) (2017-2027)
Figure Global Hereditary Angioedema Treatment Market Size (Million US$) (2017-2027)
Figure North America Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure China Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Hereditary Angioedema Treatment Sales by Manufacturer (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Manufacturer in 2021
Table Global Hereditary Angioedema Treatment Revenue by Manufacturer (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturer in 2021
Table Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Hereditary Angioedema Treatment Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Hereditary Angioedema Treatment Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Hereditary Angioedema Treatment Market
Table Key Manufacturers Hereditary Angioedema Treatment Product Type
Table Mergers & Acquisitions Planning
Table CSL Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of CSL
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Pharming Group Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of Pharming Group
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pharming Group Recent Development
Table Shire plc (Takeda Pharmaceutical Company Limited) Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of Shire plc (Takeda Pharmaceutical Company Limited)
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shire plc (Takeda Pharmaceutical Company Limited) Main Business
Table Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table Ionis Pharmaceuticals Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of Ionis Pharmaceuticals
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ionis Pharmaceuticals Main Business
Table Ionis Pharmaceuticals Recent Development
Table Ionis Pharmaceuticals Main Business
Table Ionis Pharmaceuticals Recent Development
Table Attune Pharmaceuticals Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of Attune Pharmaceuticals
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Attune Pharmaceuticals Main Business
Table Attune Pharmaceuticals Recent Development
Table BioCryst Pharmaceuticals Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of BioCryst Pharmaceuticals
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table BioCryst Pharmaceuticals Main Business
Table BioCryst Pharmaceuticals Recent Development
Table KalVista Pharmaceuticals Company Profile
Table Hereditary Angioedema Treatment Product Introduction, Application and Specification of KalVista Pharmaceuticals
Table Hereditary Angioedema Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table KalVista Pharmaceuticals Main Business
Table KalVista Pharmaceuticals Recent Development
Figure Global Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue and Growth Rate (2017-2022)
Table Global Hereditary Angioedema Treatment Sales by Regions (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Regions in 2021
Table Global Hereditary Angioedema Treatment Revenue by Regions (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Regions in 2021
Figure North America Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Europe Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure China Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Japan Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Figure Other Regions Hereditary Angioedema Treatment Sales and Growth Rate (2017-2022)
Table Global Hereditary Angioedema Treatment Sales by Big Type (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Market Share by Big Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Big Type in 2019
Table Global Hereditary Angioedema Treatment Revenue by Big Type (2017-2022)
Table Global Hereditary Angioedema Treatment Revenue Market Share by Big Type (2017-2022)
Table Global Hereditary Angioedema Treatment Revenue Market Share by Big Type in 2019
Figure Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate (2017-2022)
Figure Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Price (2017-2022)
Figure Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate (2017-2022)
Figure Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Price (2017-2022)
Figure Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate (2017-2022)
Figure Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Price (2017-2022)
Figure Global Others (Conventional Drugs, Pipeline Drugs) Sales Growth Rate (2017-2022)
Table Global Hereditary Angioedema Treatment Sales by Big Application (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Market Share by Big Application (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Big Application in 2019
Figure Global Hospital Pharmacies Sales Growth Rate (2017-2022)
Figure Global Retail Pharmacies Sales Growth Rate (2017-2022)
Figure Global Others (online pharmacies, mail pharmacies) Sales Growth Rate (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales and Growth Rate (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue and Growth Rate (2022-2027)
Table Global Hereditary Angioedema Treatment Sales Forecast by Regions (2022-2027)
Table Global Hereditary Angioedema Treatment Market Share Forecast by Regions (2022-2027)
Figure North America Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure Europe Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure China Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure Japan Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure Southeast Asia Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Figure Other Regions Sales Hereditary Angioedema Treatment Market Forecast (2022-2027)
Table Global Hereditary Angioedema Treatment Sales Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Treatment Market Share Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Treatment Sales Forecast by Application (2022-2027)
Table Global Hereditary Angioedema Treatment Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereditary Angioedema Treatment
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Hereditary Angioedema Treatment Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Hereditary Angioedema Treatment Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Hereditary Angioedema Treatment Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Hereditary Angioedema Treatment Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)